54 results about "Breathing pains" patented technology

The present invention provides the use of ATP for the manufacture of a medicine for exerting a pharmacological effect when administered to a mammal, preferably a human, selected from the group consisting of: 1°. modulating inflammation by inhibiting the inflammatory response to a strong external insult such as endotoxin (LPS) and/or phytohaemagglutinin; 2°. exerting said inhibitory effect on inflammatory response to an external stimulus even under conditions of oxidative stress, 3°. exerting a local immuno-modulating and anti-inflammatory effect in the intestine, thus preventing intestinal damage induced by a non-steroid anti-inflammatory drug (NSAIDs), 4°. exerting an immuno-modulating and anti-inflammatory effect in human intestinal cells in vitro, 5°. alleviating pulmonary symptoms, such as shortness of breath and dyspnoea, in patients suffering from an obstructive pulmonary disease, and 6°. exerting favorable clinical effects with respect to certain mental and neurological disorders and aberrant conditions. The medicine is preferably manufactured in lyophilized form.

The present invention relates to a preventive and/or therapeutic agent for hyperkalemia, and a potassium excretion promoter containing EP₄ agonist. Since EP₄ agonist promotes potassium excretion, it is useful as a preventive and/or therapeutic agent for hyperkalemia. In addition, if selective EP₄ agonist uses, it is a preventive and/or therapeutic agent for hyperkalemia without side effects. Further, if EP₄ agonist is used, it is useful as improving agent for various symptoms (e.g. paresthesia, error of perception, weakness, myoparalysis, nausea, vomit, abdominal pain, diarrhea, arrhythmia, atrioventricular block, ventricular fibrillation, atrial fibrillation, cardiac arrest, asphyxia and/or dyspnoea etc.).

The present invention discloses an oral solid preparation containing ambroxol hydrochloride and salbutamol active components. It is formed from ambroxol hydrochloride, salbutamol and auxiliary material according to a certain mixing ratio. Said oral solid preparation has the obvious synergistic action for remitting the symptoms of dyspnea, etc. due to respiratory tract obstruction diseases of bronchial asthma, chronic bronchitis and pulmonary emphysema, etc.

The invention provides a medicine for treating asthma. The medicine is prepared by the following Chinese traditional medicine materials: Thallus Laminariae, powdered shell of clam, Radix Scutellariae, Quercus canariesis, Radix Stemonae, Semen Armeniacae Amarum, Semen Persicae, Radix Platycodi, Inula britannica L. Var. Chinensis, Semen Gingko, Rhizoma Pinelliae, Radix Bupleuri, Gypsum Fibrosum, Folium Nelumbinis, Radix Glycyrrhizae, Fructus Schisandrae, Rhizoma Atractylodis Macrocephalae, Herba Reineckeae Carneae, Psilopeganum sinnense Hemsl, Pericarpium Citri Reticulatae, Radix Codonopsis and Lumbricus. The Chinese herbal prescription has good clinical effect on the asthma patient in each stage; the medicine shows good treatment effect even in the initial medication period; the symptoms such as shortness of breath, cough, expectoration of much phlegm and difficult breath are relieved; the pain of the patient is reduced. The medicine has remarkable active effects of no side effects, quickly improving the symptoms of the patient, evident curative effect, uneasy recurrence and low cost for treatment; therefore the invention has good social and economic benefits in promotion and application.

The invention relates to a traditional Chinese medicine compound injection for the treatment of livestock viral diseases, including five medicines of indigowoad leaf, honeysuckle flower, incised notopterygium rhizome, bistort rhizome and rhubarb. The invention is mainly used for virus infectious diseases and diarrhea, cough, dyspnoea, purple skin, skin petechial hemorrhage, pox-shaped scar formation on the head, face and lower abdomen and other symptoms. The medicine is prepared into the injection by the combination of the special physiological structure of the livestock, and the invention can be absorbed rapidly after muscle injection, so as to achieve the purpose of rapid onset of action.

An orally taken percarbonamide as the oxygen donor in the form of tablet, particles or powder for the patients of pneumonectasis, pneumocardial disease, respiration failure, asthma, etc contains the medicinal percarbonamide and deacetyl chitin proportionally.

The invention relates to a traditional Chinese veterinary medicine compound preparation Shuanghuanglian for injection as well as a preparation technology and an application thereof. The compound preparation comprises the components in parts by weight as follows: 1300-1700 parts of honeysuckle, 1300-3700 parts of radix scutellariae and 2500-7500 parts of fructus forsythiae. Slow-release accessories comprise 150 parts of hydroxymethyl propyl cellulose and 100 parts of sodium carboxymethyl cellulose. The compound preparation contains the slow-release accessories, so that the injection time of large animals can be reduced, and the stress response of the large animals can be reduced. The traditional Chinese veterinary medicine compound preparation for injection has antiviral, antibacterial, anti-inflammatory, antipyretic, analgesic, immunity-improving effects and the like. Veterinarian clinic proves that the compound preparation can be used for treating epidemic diarrhea; transmissible gastroenteritis; necrotic enteritis; septicemia caused by various epidemic diseases; cough, dyspnea, skin cyanosis, arthrocele which are caused by chromic respiratory diseases such as streptococcosis, haemophflussuis, contagious porcine pleuropneumonia, swine plague and the like; and porcine reproductive and respiratory syndrome and cow mastitis.

The invention discloses a medicine for treating phlegm retention obstructing lung type cardiac insufficiency and a preparation method thereof. The raw medicinal materials include fructus arctii, sarmentose pepper herb, cordate houttuynia, rongkol, fagopyrum dibotrys, Japanese balanophora, gynostemma, aster fastigiatus, hippophae rhamnoides, delphinium brunnonianum royle, fritillaria cirrhosa, ligularia lessicotal, trichosanthes kirilowii maxim, fructus broussonetiae, radix peucedani, brackish-water crab, concha meretricis seu cyclinae, sea snails, aster, aristolochia championii, textile screw pine shoot, Japanese ardisia, Japanese inula herb, semen lepidii, holy basil, flos daturae, kohlrabi, thorny elaeagnus leaves, magnets, pennycress seeds, ganoderma lucidum, prickly poppies, polygala and maire yew seeds. The medicine for treating phlegm retention obstructing lung type cardiac insufficiency has the effects of purging the lung of pathogenic fire and reducing phlegm, and mainly treats phlegm retention obstructing lung type cardiac insufficiency, treatment is based on syndrome differentiation through the theory of traditional Chinese medicine, and the medicine is high in targeting performance by adjusting body circulation and pulmonary circulation qi and blood, relieves dyspnea and edema, controls arrhythmia, adjusts blood pressure, strengthens the cardiac pumping function, and has the advantages of taking effects soon, and being high in efficiency, definite in treatment effect, short in treatment course, free of toxic and side effects, low in price and the like.

The invention relates to a traditional Chinese medicine composition for treating pneumonia. The traditional Chinese medicine composition comprises the following raw materials: platycodon grandiflorum, cocculus orbiculatus, almonds, dried orange peels, polygonum cuspidatum, isatis root, asarum, pericarpium papaveris, cinnamon, bighead atractylodes rhizome, tangerine, liquorice, pericarpium citri reticulatae viride, rhizoma anemarrhenae, mulberry leaves, rhinoceros horn powder, gleditsia officinalis, cortex lycii radicis and mint. The traditional Chinese medicine composition is based on a human body, treats both symptoms and root causes, has the effects of clearing internal heat, purging the lung, clearing heat and toxics, removing stasis, freeing the lung, relieving a cough, eliminating wind and swelling and the like, and can be used for killing bacteria infecting the body, recovering the detoxifying functions of the liver and the kidney, radically removing inflammation in the lung, removing redundant phlegm stagnation, and improving the respiratory tract to recover the normal respiratory function; through comprehensive treatment, the symptoms such as fever, shiver, cough, chest pain and dyspnea can be radically eliminated and finally the pneumonia is radically healed.

The invention discloses a drug for a stable stage of chronic obstructive pulmonary diseases and a preparation method thereof. The medicinal effective components are composed of radix astragali preparata, sun-dried ginseng, bulbus Lily, cortex lycii, herba ephedrae preparata, semen armeniacae amarum, rhizoma atractylodis, gecko, bulbus fritillariae thunbergii, seeds of snake gourds, radix trichosanthis, poria cocos, dried orange peels, radix platycodi, rhizoma pinelliae preparata, radix glycyrrhizae preparata, rhizoma alismatis, cortex moutan and radix paeoniae rubra. The drug has the effects of tonifying deficiency (invigorating qi-yin of the lung and invigorating qi of the spleen and kidney), eliminating phlegm, removing dampness, facilitating diuresis, promoting blood circulation, removing blood stasis, nourishing yin, clearing away internal heat, ventilating the lung and unclogging the viscera. The drug can be used in the stable stage of chronic obstructive pulmonary diseases, improve immunity, reduce the frequency of acute aggravation induced by infection, improve the lung function, promote oxygenation, control the disease progress and relieve cough, expectoration, asthma, anddyspnea.

Disclosed herein are aspects of a tracheal breathing tube that provides for accurate and reliable control of cannula cuff pressure. Such a tracheal breathing tube include a pressure controller through which a fluid is supplied to a cannula cuff of a tracheal breathing tube and which enables reliable indication of a level of pressure of fluid within the cannula cuff. The pressure controller serves to achieve a proper interface between the cannula cuff and a patient's trachea, thereby addressing important clinical considerations such as anesthesiologist control. Moreover, the pressure controller serves to ensure that proper force is being applied on the patient's tracheal walls by the cannula cuff to thereby limit the potential for post-surgical complications resulting from, for example, inadequate blood supply to an organ or part of the body. swelling of the patient's tracheal walls that can lead to difficulty in breathing, and the like.

The invention discloses a traditional Chinese medicine for improving anoxia endurance and a preparation method thereof, and relates to the technical field of traditional Chinese medicines.The traditional Chinese medicine is prepared from Chinese magnoliavine fruit, unibract fritillary bulbs, pericarpium citri reticulatae, fructus amomi, fructus aurantii immaturus, honey-fried herba ephedrae, bitter apricot seeds, gypsum, licorice roots, figwort roots, radix panacis quinquefolii, fructus perillae, opuntia dillenii Haw.and honey.According to the traditional Chinese medicine, honey-fried herba ephedrae, unibract fritillary bulbs, pericarpium citri reticulatae, bitter apricot seeds, gypsum, radix panacis quinquefolii, fructus perillae and honey have the effects of clearing heat, moistening the lung, eliminating dampness, eliminating phlegm and ventilating the lung to relieve asthma; licorice roots and Chinese magnoliavine fruit have the effects of tonifying the spleen and benefiting qi; fructus amomi and fructus aurantii immaturus have the effects of dissipating the dampness, promoting appetite, warming the spleen and stopping diarrha; figwort roots and opuntia dillenii Haw.have the effects of purging fire and removing toxic substances.All the ingredients are mutually compatible, the effects of clearing the heat, moistening the lung, tonifying the spleen, benefiting qi, purging fire and removing toxic substances serve as the therapeutic principles, the function of improving the anoxia endurance is achieved, and the traditional Chinese medicine can prevent and assist in treatment of an anoxic cough, asthma, dyspnea, trachitis, bronchitis, pneumonia, pulmonary emphysema and a pulmonary heart disease.

The invention discloses a medicine for treating hypotension and a preparation method thereof, and belongs to the field of traditional Chinese medicines. The effective ingredient of the traditional Chinese medicine is prepared from the following raw materials: ventilago leiocarpa benth, grapes, angelica sinensis, eclipta, textile screw pine seeds, licorice roots, longan pulp, radix rehmanniae praeparata, poria cocos, Chinese dates, stephanotis chunii, lucid ganoderma, asiatic bilberry leaves, radix polygonati officinalis, cortex acanthopanacis and odontobutis obscura. The traditional Chinese medicine is prepared from compatible and complementary medicinal materials, has the effects of strengthening tendons and bones, promoting blood vessels, tonifying liver and kidneys, nourishing yin and moistening lung, nourishing stomach and promoting generation of body fluids, strengthening spleen and homogenizing stomach, calming heart and tranquilizing and the like, can directly reach the disease part by the combination effect of the medicinal materials, has the advantages of quick response, high cure rate, no toxic or side effect and the like on treatment of dizziness, headache, inappetence, fatigue, pale face, dyspepsia, cold limbs, palpitation, dyspnea and other symptoms, is low in price and easy to prepare, and is worthy of clinical wide popularization and application.

The invention relates to a preparation for treating porcine bacterial respiratory diseases and a preparation method thereof. The medicinal composition of the preparation comprises cefquinome sulfate and panax notoginseng saponins. The invention further relates to an injection solution for treating porcine bacterial respiratory diseases. The injection solution is prepared from cefquinome sulfate, panax notoginseng saponins, a suspending agent, a dispersing agent, and injection oil for fixing the volume, wherein the cefquinome sulfate is measured by cefquinome. Cefquinome sulfate and panax notoginseng saponins in a reasonable proportion are firstly used for preparing the preparation for treating porcine bacterial respiratory diseases, wherein the panax notoginseng saponins can be used for improving the phagocytic ability of alveolar macrophages, enhancing the sterilization efficacy of cefquinome sulfate, achieving the anti-fibrosis effect, inhibiting pulmonary fibrous exudation in the porcine bacterial respiratory diseases and effectively relieving the symptom of dyspnea in time.

The invention relates to a traditional Chinese medicine compound preparation for resisting the porcine reproductive and respiratory syndrome and a preparation process of the traditional Chinese medicine compound preparation. The traditional Chinese medicine compound preparation comprises the following medicinal materials in parts by weight: 5-10 parts of honeysuckle, 5-10 parts of folium isatidis, 8-15 parts of herba houttuyniae, 8-15 parts of herba patriniae, 5-10 parts of radix paeoniae rubra, 8-15 parts of radix scutellariae, 5-10 parts of radix scrophulariae, 8-15 parts of radix astragali, 8-15 parts of mint, 5-10 parts of rhizoma phragmitis, 8-15 parts of fructus gardenia, 5-10 parts of lophatherum gracile and 5-10 parts of herba eupatorii, wherein the raw medicinal materials are prepared in parts by weight and are added with water to be stewed to form a water agent. The water agent is mainly used for treating syndromes including porcine continuous fever, thick and irregular clothing hair, anepithymia, depressed spirit, whole rubefaction, cyanosis, expiratory dyspnea, asthma, rhinorrhea, eye secretion increase and the like caused by damp and hot obstruction, invasion of lung by pathogenic warm, reverse transmission into the pericardium and unstoppable deficiency heat. The water agent has remarkable treating effects to fattening pigs and sows, and the total effective rate reaches 75% or above.